Adequacy of EBUS-TBNA specimen for mutation analysis of lung cancer.
Tugba CicekAyperi ÖztürkAydın YılmazZafer AktasFunda DemiragNalan AkyurekPublished in: The clinical respiratory journal (2019)
The study demonstrated that EBUS-TBNA provides adequate material for mutation analysis in patients with newly diagnosed adenocarcinoma or NOS lung cancer.
Keyphrases